stockrowCalumet, Inc.
CLMT Basic Materials Specialty Chemicals
Calumet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.1 billion, down 1.25% from fiscal 2024.
- Revenue
- +40.8%
- EPS
- +35.9%
- Free cash flow
- +450.7%
- Total debt
- −1.98%
Quarter to June 2026, against a year earlier
Follow CLMT
Alert me
Calumet, Inc. (CLMT) EBITDA
Calumet, Inc.'s EBITDA for fiscal 2025 was $298.5M, up 53.0% from $195.1M in fiscal 2024. Over the twelve months to 30 June 2026 it was $133.9M. Over the past ten years it has ranged from $39.1M (fiscal 2021) to $450.1M (fiscal 2023); the current reading is higher than 73% of that period. Calumet, Inc. ranks 36th of 59 Specialty Chemicals companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $298.5M | 53.00% |
| FY2024 | $195.1M | (56.65%) |
| FY2023 | $450.1M | 77.69% |
| FY2022 | $253.3M | 547.83% |
| FY2021 | $39.1M | (18.20%) |
| FY2020 | $47.8M | (76.76%) |
| FY2019 | $205.7M | (18.95%) |
| FY2018 | $253.8M | (24.71%) |
| FY2017 | $337.1M | 82.31% |
| FY2016 | $184.9M | (40.12%) |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $5.3M | — |
| Mar 2026 | −$129.8M | — |
| Dec 2025 | −$64.5M | — |
| Sep 2025 | $322.9M | — |
| 42 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| CBT Cabot Corporation compare | $673.0M |
| FUL H. B. Fuller Company compare | $564.5M |
| AVNT Avient Corporation compare | $505.6M |
| ASH Ashland Inc. compare | $336.0M |
| SXT Sensient Technologies Corporation compare | $317.0M |
| PRM Perimeter Solutions, SA compare | $230.0M |
| HWKN Hawkins, Inc. compare | $181.8M |
| CLMT Calumet, Inc. | $133.9M |
| WDFC WD-40 Company compare | $119.3M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on CLMT
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement